Ignite Creation Date:
2024-05-06 @ 5:44 PM
Last Modification Date:
2024-10-26 @ 2:34 PM
Study NCT ID:
NCT05417373
Status:
UNKNOWN
Last Update Posted:
2022-06-14
First Post:
2022-06-06
Brief Title:
Algorithms to Diagnose Pulmonary Arterial Hypertension
Sponsor:
RenJi Hospital
Organization:
RenJi Hospital
Study Overview
Official Title:
Development and Validation of a Radiomics-based Diagnosis Model for Pulmonary Arterial Hypertension
Status:
UNKNOWN
Status Verified Date:
2022-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators intend to evalute the value of radiomics signature of pulmonary vessels from chest computed tomography CT for dianosis and prognosis of pulmonary arterial hypertension
Detailed Description:
Pulmonary arterial hypertension PAH is a heterogeneous disorder composed of varying pathobiology that may involve multiple clinical conditions Computed tomography CT is a minimally invasive imaging technique capable of providing both high contrast and high resolution detail of the lungs and arteries Application of radiomics as prognosis and diagnosis tools could quantifies high-dimensional features from CT data to investigate vescualr heterogeneityDevelopment and validation of PAH diagnosis Algorithms based on radiomics may serve as a complementary readout to current CT-based metrics and provide valuable evidence to make the treatment management decision in early PAH
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None